Molecular modifications and modulation of adverse actions of muscle relaxants in anesthesiology.
D000758:Anesthesia; D002626:Chemistry, Pharmaceutical; D003650:Decamethonium Compounds / Q000037:antagonists & inhibitors; D006801:Humans; D006868:Hydrolysis; D009125:Muscle Relaxants, Central / Q000009:adverse effects* / Q000138:chemical synthesis; D009466:Neuromuscular Blocking Agents / Q000037:antagonists & inhibitors; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors; D009435:Synaptic Transmission / Q000187:drug effects
D003650:Decamethonium Compounds; D009125:Muscle Relaxants, Central; D009466:Neuromuscular Blocking Agents; D003473:Neuromuscular Nondepolarizing Agents